The global deferasirox market is witnessing steady growth as healthcare systems increasingly focus on managing chronic blood disorders associated with iron overload. Deferasirox, an oral iron chelation therapy, plays a critical role in reducing excess iron accumulation in patients who undergo frequent blood transfusions. The increasing prevalence of hematological disorders, advancements in...